Warning: count(): Parameter must be an array or an object that implements Countable in /home/hmc/public_html/wp-content/plugins/formcraft3/formcraft-main.php on line 1013
Welcome to (Management of Chronic Lymphoblastic Leukemia Post-Activity Assessment)
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
This test is composed of 4 questions based on the information provided to you during the activity.
You will have two attempts to complete this test.
The 30 minutes which will allow enough time to search for the correct answers
You must exceed the passing score (60%) in order to receive your certificate.
NCCCR- Management of CLL- 11 July
0 of 4 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 4 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Well Done 🙂
Del(11q) abnormality is associated with a favorable prognosis and the longest Median survival.CorrectIncorrect
A “watch and wait” approach is appropriate for asymptomatic patients with early-stage, low risk Disease (Binet stage A).CorrectIncorrect
Which of the following is correct regarding to ibrutinib?CorrectIncorrect
IVIG may be considered in patients with serum IgG < 500 mg/dL and who have recurrent infections requiring intravenous antibiotics or hospitalization.CorrectIncorrect